Free Trial

Athira Pharma (ATHA) SEC Filings & 10K Form

Athira Pharma logo
$0.39 +0.02 (+5.95%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.39 0.00 (-0.26%)
As of 08/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Athira Pharma SEC Filings

DateFilerForm TypeView
07/02/2025
3:32 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:33 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:33 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
6:33 PM
Athira Pharma (Subject)
Worthington Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
6:34 PM
Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
6:36 PM
Athira Pharma (Subject)
San Martin Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
6:37 PM
Athira Pharma (Subject)
Litton Mark James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
4:32 PM
Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:33 PM
Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:34 PM
Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:34 PM
Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:35 PM
Athira Pharma (Issuer)
Romano Kelly A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:36 PM
Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:37 PM
Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
3:15 PM
Athira Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2025
3:22 PM
Athira Pharma (Subject)
Oliveira Steven Michael (Filed by)
Form SCHEDULE 13G
03/12/2025
4:20 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 4/A
03/04/2025
3:28 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:29 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:29 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:30 PM
Athira Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:10 PM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:21 AM
Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:59 AM
Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
01/02/2025
7:02 PM
Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:04 PM
Athira Pharma (Subject)
Worthington Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:05 PM
Athira Pharma (Subject)
Litton Mark James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:06 PM
Athira Pharma (Subject)
San Martin Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
12:15 PM
Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G
10/31/2024
3:16 PM
Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
10/28/2024
11:15 PM
Athira Pharma (Filer)
Form EFFECT
10/21/2024
5:24 AM
Athira Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2024
8:50 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4/A
10/03/2024
6:07 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:08 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:10 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:13 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:17 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:05 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
8:00 AM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
6:47 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
09/05/2024
6:48 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:49 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:51 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM
Athira Pharma (Subject)
Litton Mark James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATHA) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners